Suppr超能文献

综合分析确定了一种用于结直肠癌诊断和预后的九微小RNA特征生物标志物。

Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer.

作者信息

Di Ziyang, Di Maojun, Fu Weihua, Tang Qiang, Liu Yanwei, Lei Peijie, Gu Xinsheng, Liu Tong, Sun Min

机构信息

Department of General Surgery, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.

Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China.

出版信息

Front Genet. 2020 Mar 20;11:192. doi: 10.3389/fgene.2020.00192. eCollection 2020.

Abstract

BACKGROUND

Colorectal cancer (CRC) is the third most lethal and malignant type of cancer in the world. Abnormal expression of human microRNA-200a (hsa-miRNA-200a or miR-200a) has previously been characterized as a clinically noticeable biomarker in several cancers, but its role in CRC is still unclear.

METHODS

Three CRC miRNA expression datasets were integratively analyzed by Least Absolute Shrinkage and Selector Operation (LASSO) and Support Vector Machine-Recursive Feature Elimination (SVM-RFE) algorithms. Nine candidate miRNAs were identified and validated for diagnostic and prognostic capability with the prediction model. The potential roles of the tumor suppressor miR-200a-3p in invasion, migration, and epithelial-mesenchymal transition of CRC cells were elaborated by studies.

RESULTS

Nine miRNAs (miR-492, miR-200a, miR-338, miR-29c, miR-101, miR-148a, miR-92a, miR-424, and miR-210) were identified as potentially useful diagnostic biomarkers in the clinic. The overall accuracy rate of the nine miRNAs in the diagnostic model was 0.94, 0.89, and 0.978 in the testing, validation, and independent validation dataset, respectively. CRC patients in the GSE29622 cohort were separated by the prognostic model into the low-risk score group and the high-risk score group. The area under the receiver operating characteristic curve (AUC) was 0.872 and 0.783 for predicting the 1- to 10-year survival of CRC patients. The performance of the prognostic model was validated by an independent TCGA-Colon Adenocarcinoma (COAD) dataset with AUC values between 0.911 and 0.796 in predicting 1- to 10-year survival. Nomograms comprising risk scores, tumor stage, and TNM staging were generated for predicting 1-, 3-, and 5-year overall survival (OS) in the GSE29622 and TCGA-COAD datasets. Colony formation, invasion, and migration in DLD1 and SW480 cells were suppressed by overexpression of miR-200a-3p. Inhibition of miR-200a-3p function contributed to abnormal colony formation, migration, invasion, and epithelial-mesenchymal transition (EMT). miR-200a-3p binding sites were located within the 3'-untranslated region (3'-UTR) of the Forkhead box protein A1 (FOXA1) mRNA.

CONCLUSION

We developed and validated a diagnostic and prognostic prediction model for CRC. miR-200a-3p was determined to be a potential diagnostic and prognostic biomarker for CRC.

摘要

背景

结直肠癌(CRC)是全球第三大致命性和恶性程度最高的癌症类型。人类微小RNA-200a(hsa-miRNA-200a或miR-200a)的异常表达先前已被表征为几种癌症中临床上值得注意的生物标志物,但其在结直肠癌中的作用仍不清楚。

方法

通过最小绝对收缩和选择算子(LASSO)及支持向量机递归特征消除(SVM-RFE)算法对三个结直肠癌微小RNA表达数据集进行综合分析。鉴定出九个候选微小RNA,并通过预测模型验证其诊断和预后能力。通过研究阐述了肿瘤抑制因子miR-200a-3p在结直肠癌细胞侵袭、迁移和上皮-间质转化中的潜在作用。

结果

九个微小RNA(miR-492、miR-200a、miR-338、miR-29c、miR-101、miR-148a、miR-92a、miR-424和miR-210)被鉴定为临床上潜在有用的诊断生物标志物。九个微小RNA在诊断模型中的总体准确率在测试、验证和独立验证数据集中分别为0.94、0.89和0.978。GSE29622队列中的结直肠癌患者通过预后模型被分为低风险评分组和高风险评分组。用于预测结直肠癌患者1至10年生存率的受试者工作特征曲线(AUC)下面积分别为0.872和0.783。通过独立的TCGA-结肠腺癌(COAD)数据集验证了预后模型的性能,该数据集在预测1至10年生存率时的AUC值在0.911至0.796之间。生成了包含风险评分、肿瘤分期和TNM分期的列线图,用于预测GSE29622和TCGA-COAD数据集中的1年、3年和5年总生存率(OS)。miR-200a-3p的过表达抑制了DLD1和SW480细胞中的集落形成、侵袭和迁移。miR-200a-3p功能的抑制导致集落形成、迁移、侵袭和上皮-间质转化(EMT)异常。miR-200a-3p结合位点位于叉头框蛋白A1(FOXA1)mRNA的3'-非翻译区(3'-UTR)内。

结论

我们开发并验证了一种用于结直肠癌的诊断和预后预测模型。确定miR-200a-3p为结直肠癌潜在的诊断和预后生物标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验